Incidence and Impact of RAS‐Like Opacities During Preserved Lung Function After Lung Transplantation
Clinical Transplantation · 2026-07 · 40 (7)
DOI: 10.1111/ctr.70605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 03.07.2026. Verfasst von Laura H Peräkylä und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Graft Rejection, Lung, Lung Transplantation, Tomography, X-Ray Computed. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
Chronic lung allograft dysfunction (CLAD) limits survival after lung transplantation. Restrictive allograft syndrome (RAS) is the most aggressive subtype of CLAD, and its diagnosis requires permanent lung function decline, restrictive lung physiology, and RAS‐like opacities (RLOs) on lung imaging. We aimed to investigate the incidence of RLOs in patients with preserved lung function, and to determine whether RLOs later progressed into RAS‐type CLAD or were associated with adverse clinical outcome.
Methods
We retrospectively reviewed the presence of RLOs during stable and preserved lung function (FEV1> 80% of baseline) from serial CT scans of 167 consecutive adult lung transplant patients. RLOs were evaluated from serial CT scans for their distribution, radiological morphology, and extent. The impact of RLOs on lung function, CT‐volumetry, and patient outcome was determined.
Results
Eleven patients (7%) with preserved lung function developed RLOs at a median of 3.0 years after transplantation. The RLOs localized predominantly in the upper lobes, consisted of ground glass, nodular, and reticular opacities, and consolidations, and progressed over time leading to extensive pattern of RLOs in 45% of the 11 patients. Eight patients (74%) with RLOs later developed CLAD at a median of 2.8 years after occurrence of RLOs. Their CLAD phenotype was RAS in only two patients and Mixed in five patients (63%). The occurrence of RLOs during preserved lung function was not associated with reduced long‐term survival.
Conclusions
The presence of progressing RLOs detected in lung transplant recipients with preserved lung function was not associated with reduced survival during follow‐up. The majority of patients with RLOs developed CLAD which was mostly of mixed phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Department of Radiology, Medical Imaging Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Department of Pulmonology, Heart and Lung Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
ORCID-Profile: Laura H Peräkylä, Antti I Nykänen, Risto I Kesävuori, Jussi M Tikkanen, Teemu O Mäkelä, Peter M Raivio
Zitieren
APA
Peräkylä, L. H., Nykänen, A. I., Kesävuori, R. I., Piilonen, A. K., Tikkanen, J. M., Mäkelä, T. O., Halme, M. K., & Raivio, P. M. (2026). Incidence and Impact of RAS‐Like Opacities During Preserved Lung Function After Lung Transplantation. Clinical Transplantation, 40(7). https://doi.org/10.1111/ctr.70605
Vancouver
Peräkylä LH, Nykänen AI, Kesävuori RI, Piilonen AK, Tikkanen JM, Mäkelä TO, et al. Incidence and Impact of RAS‐Like Opacities During Preserved Lung Function After Lung Transplantation. Clinical Transplantation. 2026;40(7). doi:10.1111/ctr.70605
BibTeX
@article{Perkyl2026,
author = {Peräkylä, Laura H and Nykänen, Antti I and Kesävuori, Risto I and Piilonen, Anneli K and Tikkanen, Jussi M and Mäkelä, Teemu O and Halme, Maija K and Raivio, Peter M},
title = {Incidence and Impact of RAS‐Like Opacities During Preserved Lung Function After Lung Transplantation},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {7},
doi = {10.1111/ctr.70605}
}
EUVIMED